2nd Quarter - Report

OGR for PFIZER INC

Firm
OGR
Client
Income
$60,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing; implementation of H.R.5376, Inflation Reduction Act of 2022 (P.L.117-169). Issues related to COVID-19 response including vaccines and anti-viral therapies. Issues related to the 340B drug discount program. Antimicrobial Resistance. Issues related to Medical Supply Chain Resiliency Act (S.2115/H.R.4307).

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 4307 (118th), S. 2115 (118th), H.R. 5376 (118th)

Medicare/Medicaid MMM

Issues related to Medicare Part D Program.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to TRIPS Waiver.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.